about
Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin diseaseEQ-5D in skin conditions: an assessment of validity and responsivenessSpotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativaNucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges.Development of a Quality-of-Life Measure for Hidradenitis Suppurativa.Increased prevalence of metabolic syndrome in patients with acne inversa.Update on hidradenitis suppurativa: connecting the tracts.European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.What we know about primary dysmenorrhea today: a critical review.Rapid healing of chronic ulcerations and improvement in range of motion after fractional carbon dioxide (CO2) treatment after CO2 excision of hidradenitis suppurativa axillary lesions: A case report.Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, MinnesotaAcne inversa (Hidradenitis suppurativa): A review with a focus on pathogenesis and treatmentHidradenitis suppurativa: number of diagnosed patients, demographic characteristics, and treatment patterns in the United States.Hidradenitis suppurativa: the role of immune dysregulation.Hidradenitis suppurativa in children and adolescents: a review of treatment options.Quality of Life of Patients With Pyoderma Gangrenosum and Hidradenitis Suppurativa.The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities.The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.EQ-5D in Central and Eastern Europe: 2000-2015.Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa / hidradenitis suppurativa.Prodromal symptoms in hidradenitis suppurativa.The burden of common skin diseases assessed with the EQ5D™: a European multicentre study in 13 countries.Surgical Management of Hidradenitis Suppurativa: A 14-Year Retrospective Review of 98 Consecutive Patients.High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics.Depression in patients with hidradenitis suppurativa.Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum.Is hidradenitis suppurativa associated with anaemia?: a population-based and hospital-based cross-sectional study from Denmark.Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients.Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study.The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa.Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients.Hidradenitis Suppurativa, Intimate Partner Violence, and Sexual Assault.Descriptive Epidemiology of Hidradenitis Suppurativa in Greece: A Study of 152 Cases.Association of Resilience With Depression and Health-Related Quality of Life for Patients With Hidradenitis Suppurativa.Preliminary Validation of the HS-QoL: A Quality-of-Life Measure for Hidradenitis Suppurativa.Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study.Recommendations for the management of comorbidity in hidradenitis suppurativa.Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa.
P2860
Q26828789-993A197A-AFB7-4168-BE21-B38B56B049E6Q27011276-D96741C9-6D1A-4BA5-BE07-6CE11A47C7EDQ28069719-00FAFB35-645A-483D-AD31-E9448D8BA981Q28085200-F3CF6ADD-E7B4-4EA8-BF1A-793BB19AAA36Q33922455-D667CD69-99CD-445C-BF22-D3D4E24AB110Q34168423-22DDB155-54D2-41E7-B0C7-2A7BAFC93A62Q34780340-0C3ECE15-0D63-4AF7-AC12-93DB6BE9BBE7Q35553032-AF2EA577-FD93-4FAE-AD36-AB68475F396AQ35766030-55C09233-97D7-4E5F-B1CD-547DCD05246FQ35981538-04138A94-EC07-46DE-9219-E7CF20DF73A4Q36521997-BD74D2AD-2EB3-4D24-941C-692DD8A33753Q36612696-56D2F326-9326-4C9D-97C2-C398487E19AAQ38210521-21566B5A-D119-4B6E-B88F-3A4C4754E712Q38222887-76BA9287-E399-4564-B9F5-CD92184112CCQ38252450-DC549DEC-53F0-4401-B75D-6B87598C5203Q38379853-632E2DB4-5C2F-4875-8CFB-3FBDD44BD870Q38558963-9B1A6B90-296D-479E-882E-4F6A6A118C1FQ38665824-BFF992B8-77E4-414D-B06C-335ED9F6F368Q38732025-386E4DE3-E428-4418-B352-0041D74CA975Q38912637-0763AB79-430B-45DE-81BA-4D6455B18318Q38929328-27F5E886-E182-41C2-97EE-E430EA4616B8Q38931280-FF8897BD-3C6E-43D5-9C36-71F2DEB1E6E0Q38962830-1C1A07B8-D5E8-40D2-BDEA-241292D6C9A5Q39054955-BFB212B1-7B58-441C-91A3-C9F4326BEBC8Q39193207-BAAEF6E9-E751-4B20-98DE-159869AB4F9AQ39480879-1AA40C8A-3434-435A-ACF4-AC57F338C2DFQ39651729-AAF8542A-DE30-498C-8BE1-6ED0980CC5F7Q40881042-9215BB2B-36E7-4441-B55F-1935CDD88064Q40962223-AAC69571-E046-401C-986B-8DE6977152E2Q41438214-09D3E146-C938-4D95-8D25-487C6903936EQ41644465-4BA07606-A4E8-48FF-A210-F882290C5FC8Q42237268-BFF2C384-F39B-47B8-92C7-45E9363394EFQ45338264-338774FA-9D17-4565-A70C-A208BA0CE6DDQ47377811-0DBFD0D7-2E74-4103-846F-680FB7C01AB5Q47411192-316DB46D-2668-4347-B274-89FC163E4A15Q47548765-0215344B-BFF3-4440-B618-CBF64560892FQ47602388-5DD25BFE-21B4-46D2-BDEF-5FD2AD3CA49DQ47674064-F47AB29F-13CF-4ECE-A01D-25F67F12B5A2Q47801282-E5E028DE-E1CB-4EB3-B307-87E795B9CA03Q48277846-6AAE8EFA-FF83-4E41-BDA5-C909CBD05C5C
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Psychophysical aspects of hidradenitis suppurativa.
@en
Psychophysical aspects of hidradenitis suppurativa.
@nl
type
label
Psychophysical aspects of hidradenitis suppurativa.
@en
Psychophysical aspects of hidradenitis suppurativa.
@nl
prefLabel
Psychophysical aspects of hidradenitis suppurativa.
@en
Psychophysical aspects of hidradenitis suppurativa.
@nl
P2093
P356
P1476
Psychophysical aspects of hidradenitis suppurativa.
@en
P2093
Andrzej Bieniek
Jacek C Szepietowski
Lukasz Matusiak
P304
P356
10.2340/00015555-0866
P577
2010-05-01T00:00:00Z